Dr. Ferdinand Massari, commonly known as Ferd, has spent his career in clinical medicine. He got his start as a Staff Fellow at the National Institute of Allergy and Immunology, part of the National Institutes of Health. After a year, Ferd Massari, MD, was promoted to Chief Medical Staff Fellow.In the late 1980s, Dr. Ferd Massari shifted to industry-based research and development, where he would remain for the rest of his career. He spent eight years with Merck & Co., Inc., ushering through new products, including Crixivan, a protease inhibitor used to treat human immunodeficiency virus infection, vaccines, and antibiotics. He also served on the U.S. marketing team responsible for educating patients about Crixivan’s usage and effectiveness.In 1998, Pharmacia & Upjohn recruited him for the post of Vice President of Clinical Research. For the next four years, Dr. Ferd Massari oversaw global studies in urology, women’s health, and infectious diseases. During this period, his team shepherded through an antibiotic new drug application (NDA) in record time, resulting in the most successful product launch in company history up to that time. In the years that followed, Dr. Ferd Massari achieved similar gains. Notably, as the Senior Vice President with Coley Pharmaceutical Group, he designed a go/no-go study that yielded results within three months. Likewise, while heading global clinical research for Shire Human Genetic Therapies, his team completed a critical NDA in 10 weeks, more than five months ahead of schedule. Today, he leads a biotech and pharmaceutical consulting firm.Dr. Ferdinand Massari earned a MD from Jefferson Medical College at Thomas Jefferson University. Outside of work, he donates to that institution, along with Massachusetts General Hospital, the Metropolitan Opera, and the Preservation Society of Newport County. He spends his leisure time horseback riding and sailing.